These two cancer drugs will soon be PBS-listed
Two more cancer drugs have become available on the PBS from 1st April. They are:
- Brentuximab vedotin (Adcetris) – an antibody-drug conjugate for patients with relapsed or refractory Hodgkins lymphoma
- Vismodegib (Erivedge) – for metastatic or locally advanced basal cell carcinoma.
Three other cancer drugs had PBS listings announced from 1 February:
- Ceritinib (Zykadia) – for locally advanced (stage IIIb) or metastatic (stage IV) non-small cell lung